BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen YC, Li CY, Tsai SJ, Chen YC. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals. World J Clin Cases 2019; 7(11): 1270-1281 [PMID: 31236391 DOI: 10.12998/wjcc.v7.i11.1270]
URL: https://www.wjgnet.com/1948-5182/full/v7/i11/1270.htm
Number Citing Articles
1
Renin Chang, Ming Li Chen, Cheng-Li Lin, Yao-Min Hung, James Cheng-Chung Wei. Association of Infection With Human Papillomavirus and Development of End-Stage Kidney Disease in TaiwanJAMA Network Open 2020; 3(10): e2022107 doi: 10.1001/jamanetworkopen.2020.22107
2
Pei-Yuan Su, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, I-Ling Liu, Ya-Huei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Shun-Sheng Wu, Fu-Yuan Siao, Hsu-Heng Yen. Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective StudyJournal of Clinical Medicine 2021; 10(22): 5236 doi: 10.3390/jcm10225236
3
Hsu-Heng Yen, Pei-Yuan Su, I-Ling Liu, Ya-Yuei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Chia-Wei Yang, Yang-Yuan Chen. Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patientsPeerJ 2021; 9: e10944 doi: 10.7717/peerj.10944
4
Hsu-Heng Yen, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, Siou-Ping Huang, I-Ling Liu, Ya-Huei Zeng, Fang-Chi Yang, Fu-Yuan Siao, Mei-Wen Chen, Pei-Yuan Su. Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness AnalysisJournal of Clinical Medicine 2022; 11(7): 1853 doi: 10.3390/jcm11071853
5
Giovana Rossato, Cristiane Valle Tovo, Paulo Roberto Lerias de Almeida. Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimesThe Brazilian Journal of Infectious Diseases 2020; 24(1): 25 doi: 10.1016/j.bjid.2019.10.011
6
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo. Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysisNefrología 2021; 41(5): 578 doi: 10.1016/j.nefro.2021.01.008
7
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo. Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysisNefrología (English Edition) 2021; 41(5): 578 doi: 10.1016/j.nefroe.2021.11.011
8
Chien‐Hsueh Tung, Chung‐Yi Li, Yen‐Chun Chen, Yi‐Chun Chen. Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren’s syndrome: 15‐year analysis of the national database of TaiwanJournal of Viral Hepatitis 2021; 28(5): 809 doi: 10.1111/jvh.13481
9
Hsu-Heng Yen, Pei-Yuan Su, Ya-Huei Zeng, I-Ling Liu, Siou-Ping Huang, Yu-Chun Hsu, Yang-Yuan Chen, Chia-Wei Yang, Shun-Sheng Wu, Kun-Ching Chou, Tatsuo Kanda. Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world settingPLOS ONE 2020; 15(8): e0237582 doi: 10.1371/journal.pone.0237582
10
Patricio E. Ray, Asha Moudgil, Aditi Sinha. Pediatric Nephrology2021; : 1 doi: 10.1007/978-3-642-27843-3_101-1